IDL Diagnostics AB (publ) (STO:IDLDX)
0.3500
-0.0140 (-3.85%)
Mar 4, 2026, 5:01 PM CET
IDL Diagnostics AB Revenue
In the year 2025, IDL Diagnostics AB had annual revenue of 53.11M SEK, down -7.54%. IDL Diagnostics AB had revenue of 16.30M in the quarter ending December 31, 2025, with 6.11% growth.
Revenue
53.11M
Revenue Growth
-7.54%
P/S Ratio
1.52
Revenue / Employee
2.66M
Employees
20
Market Cap
80.63M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 53.11M | -4.33M | -7.54% |
| Dec 31, 2024 | 57.44M | 14.40M | 33.45% |
| Dec 31, 2023 | 43.04M | 6.05M | 16.37% |
| Dec 31, 2022 | 36.99M | 24.99M | 208.32% |
| Dec 31, 2021 | 12.00M | 11.91M | 14,180.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 34.97B |
| Swedish Orphan Biovitrum AB | 28.24B |
| Medicover AB | 25.74B |
| Sectra AB | 3.47B |
| Iconovo AB | 14.53M |
| Scandinavian ChemoTech AB | 12.29M |
| Neola Medical AB | 8.28M |
| Spago Nanomedical AB | 4.82M |